Successful Treatment of a Miliary Metastatic NSCLC Patient With Activating EGFR Exon 20 Insertion Mutation with Response to Poziotinib

被引：6
|
作者：
Yang, Juyin [1 ]
Yang, Jian [2 ]
Ban, Shao [3 ]
Li, Xinmin [2 ]
Chen, Xingde [4 ]
Yang, Jihua [4 ]
Qian, Jun [2 ]
机构：
[1] Kunming Med Univ, Affiliated Dehong Peoples Hosp, Dept Pharm, Dehong, Yunnan, Peoples R China
[2] Kunming Med Univ, Affiliated Dehong Peoples Hosp, Dept Cardiothorac Surg, 13 Yonghan St, Dehong 678400, Yunnan, Peoples R China
[3] Kunming Med Univ, Affiliated Dehong Peoples Hosp, Dept Cardiovasc Med, Dehong, Yunnan, Peoples R China
[4] Kunming Med Univ, Affiliated Dehong Peoples Hosp, Dept Pathol, Dehong, Yunnan, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 09期
关键词：
D O I：
10.1016/j.jtho.2019.04.031
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E198 / E200
页数：3
相关论文
共 50 条
  • [21] Preliminary Results of a Phase II Study of Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC
    Elamin, Y.
    Robichaux, J.
    Heymach, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (08) : S1536 - S1536
  • [22] Poziotinib treatment in intractable NSCLC: Epidermal growth factor receptor and human epidermal growth factor receptor 2 exon 20 insertion mutation disease
    Rosell, Rafael
    Zorrilla, Andres F. Cardona
    EUROPEAN JOURNAL OF CANCER, 2021, 149 : 233 - 234
  • [23] Tumor Tissue and Plasma EGFR Exon 20 Insertion Mutation Status in NSCLC Patients Treated with Sunvozertinib
    Wang, M.
    Fan, Y.
    Sun, M.
    Wang, Y.
    Zhao, Y.
    Jin, B.
    Hu, Y.
    Han, Z.
    Song, X.
    Liu, A.
    Tang, K.
    Ding, C.
    Liang, L.
    Wu, L.
    Gao, J.
    Wang, J.
    Cheng, Y.
    Zhou, J.
    He, Y.
    Dong, X.
    Yao, Y.
    Yu, Y.
    Wang, H.
    Sun, S.
    Huang, J.
    Fang, J.
    Li, W.
    Wang, L.
    Ren, X.
    Zhou, C.
    Hu, Y.
    Zhao, D.
    Yang, R.
    Xu, F.
    Huang, Y.
    Pan, Y.
    Cui, J.
    Xu, Y.
    Zhu, X.
    Shi, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S150 - S150
  • [24] Prevalence And Outcomes of EGFR Exon 20 Insertion Mutation In NSCLC: Princess Margaret Cancer Center Experience
    Mittal, A.
    Hueniken, K.
    Cheng, S.
    Zhan, L. J.
    Brown, C.
    Mai, V.
    Lee, J.
    Adewole, O. O.
    Herman, J.
    Sabouhanian, A.
    Storm, E.
    Chowdhury, M. T.
    Moore, A.
    Walia, P.
    Hoxha, T.
    Parker, J.
    Patel, D.
    Balantaram, K.
    Khan, K.
    Garcia, M.
    Schimd, S.
    Sacher, A. G.
    Bradbury, P. A.
    Shepherd, F. A.
    Leighl, N. B.
    Liu, G.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S245 - S245
  • [25] Real-World Response and Outcomes in Patients With NSCLC With EGFR Exon 20 Insertion Mutations
    Ou, Sai-Hong Ignatius
    Lin, Huamao M.
    Hong, Jin-Liern
    Yin, Yu
    Jin, Shu
    Lin, Jianchang
    Mehta, Minal
    Nguyen, Danny
    Neal, Joel W.
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (10):
  • [26] EGFR exon 20 insertion mutation in Japanese lung cancer
    Sasaki, Hidefumi
    Endo, Katsuhiko
    Takada, Minoru
    Kawahara, Masaaki
    Kitahara, Naoto
    Tanaka, Hisaichi
    Okumura, Meinoshin
    Matsumura, Akihide
    Luchi, Keiji
    Kawaguchi, Tomoya
    Kawano, Osamu
    Yukiue, Haruhiro
    Yokoyama, Tomoki
    Yano, Motoki
    Fujii, Yoshitaka
    LUNG CANCER, 2007, 58 (03) : 324 - 328
  • [27] Preclinical Modeling of Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutations
    Lee, Yusoo
    Kim, Tae Min
    Kim, Dong-Wan
    Kim, Soyeon
    Kim, Miso
    Keam, Bhumsuk
    Ku, Ja-Lok
    Heo, Dae Seog
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (09) : 1556 - 1566
  • [28] Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations
    Bazhenova, L.
    Yang, J. Chih-Hsin
    Wang, M.
    Mitchell, P.
    Camidge, D. Ross
    Fang, J.
    Nian, W.
    Chiu, C. -H.
    Zhou, J.
    Zhao, Y.
    Su, W. -C.
    Yang, T. -Y.
    Zhu, V. W.
    Millward, M.
    Fan, Y.
    Huang, W. -T.
    Cheng, Y.
    Jiang, L.
    Zheng, L.
    Janne, P. A.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E3 - E3
  • [29] Durable response to immunotherapy plus chemotherapy in a patient with untreated, brain-metastatic, EGFR exon 20 insertion mutation lung adenocarcinoma A case report
    Nong, Jingying
    Gu, Yanfei
    Yao, Shuyang
    Zhang, Yi
    MEDICINE, 2021, 100 (29) : E26650
  • [30] Sunvozertinib in NSCLC Patients with EGFR Exon20 Insertion Mutations: Effect of Prior Treatment
    Yang, J. C. -H.
    Wang, M.
    Mitchell, P.
    Fang, J.
    Nian, W.
    Chiu, C-H.
    Zhou, J.
    Zhao, Y.
    Su, W. -C.
    Camidge, R.
    Yang, T. -Y.
    Zhu, V.
    Millward, M.
    Fan, Y.
    Huang, W. -T.
    Cheng, Y.
    Jiang, L.
    Brungs, D.
    Bazhenova, L. B.
    Lee, C. K.
    Gao, B.
    Zheng, L.
    Janne, P.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S410 - S411
12345